Literature DB >> 11744480

Characterization of patients presenting with male factor infertility in an equal access, no cost medical system.

R A Costabile1, M Spevak.   

Abstract

OBJECTIVES: Demographic information on patients presenting for the diagnosis and treatment of male factor infertility has been limited in the past by the paucity of subspecialty trained providers and concentrated sequential patient information. Previously reported studies looking at the characteristics of patients being evaluated for male subfertility may represent a selected subset of patients able to access these services. The changes in the diagnostic modalities available in the 1990s and new diagnostic categories may also affect the characterization of patients seen with the diagnosis of male factor infertility.
METHODS: A retrospective analysis was performed using a centralized database of patient records at a single military male infertility clinic. Seven hundred consecutive patients were studied to obtain information on patient and spouse age, race, length of subfertile period, medical history and examination, and laboratory evaluation. A single provider categorized the etiology of male factor infertility after the evaluation.
RESULTS: The mean patient age was 36 years (range 17 to 68). The mean spouse age was 31.2 years (range 19 to 50). The mean subfertile period was 5.5 years (range 0.5 to 35). Of the 700 patients, 51% were white, 10% African American, 2% Hispanic, and 37% other/unknown. Eleven percent of the patients were active smokers. The most common etiologic category groups describing male subfertility were previous vasectomy (56%), varicocele (14%), idiopathic infertility (8%), and nonobstructive azoospermia (6%).
CONCLUSIONS: An equal access, no cost medical system mirrors the demographics of the military population served. The clinical characteristics of patients presenting with male factor infertility have changed significantly during the past 30 years. Obstruction from a previous vasectomy is now the most common presenting complaint of patients visiting an infertility clinic. Vasectomy reversal may be more frequently requested when the cost is not a factor in providing fertility services. Idiopathic male factor infertility occurs in less than 10% of patients.

Entities:  

Mesh:

Year:  2001        PMID: 11744480     DOI: 10.1016/s0090-4295(01)01400-5

Source DB:  PubMed          Journal:  Urology        ISSN: 0090-4295            Impact factor:   2.649


  6 in total

Review 1.  [Therapy for infertile couples].

Authors:  H Sperling; A Eisenhardt; M Becker; H Rübben
Journal:  Urologe A       Date:  2005-10       Impact factor: 0.639

2.  A retrospective review of factors associated with vasovasostomies in United States military members.

Authors:  J Masterson; E Avalos; M Santomauro; R Walters; C Marguet; J L'Esperance; D Crain
Journal:  Curr Urol       Date:  2012-12-21

3.  PROTAMINE1 and PROTAMINE2 genes expression in the sperms of oligoasthenospermic individuals and intrauterine insemination candidates couples: Is there any significant differences?

Authors:  Roshanak Aboutorabi; Mohsen Asghari; Abbas Bakhteyari; Shokoofeh Baghazadeh; Fatemeh Sadat Mostafavi
Journal:  Adv Biomed Res       Date:  2016-10-26

Review 4.  The epidemiology and etiology of azoospermia.

Authors:  Marcello Cocuzza; Conrado Alvarenga; Rodrigo Pagani
Journal:  Clinics (Sao Paulo)       Date:  2013       Impact factor: 2.365

5.  Metabolic Fingerprinting of Seminal Plasma from Non-obstructive Azoospermia Patients: Positive Versus Negative Sperm Retrieval.

Authors:  Kambiz Gilany; Naser Jafarzadeh; Ahmad Mani-Varnosfaderani; Arash Minai-Tehrani; Mohammed Reza Sadeghi; Mahsa Darbandi; Sara Darbandi; Mehdi Amini; Babak Arjmand; Zhamak Pahlevanzadeh
Journal:  J Reprod Infertil       Date:  2018 Apr-Jun

Review 6.  Thoughts on the popularity of ICSI.

Authors:  Mounia Haddad; Joshua Stewart; Philip Xie; Stephanie Cheung; Aysha Trout; Derek Keating; Alessandra Parrella; Sherina Lawrence; Zev Rosenwaks; Gianpiero D Palermo
Journal:  J Assist Reprod Genet       Date:  2020-11-06       Impact factor: 3.412

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.